Welcome to SDEE

Welcome to San Diego Entrepreneurs Exchange! 

The San Diego Entrepreneurs Exchange (SDEE) is a nonprofit 501(c)(3) organization run by local entrepreneurs for entrepreneurs and pre-entrepreneurs interested in Life Sciences, Biotech, Pharma, Medical Devices, Tech and Alternative Energy. SDEE was founded to provide a voice and resources for early stage startups, to encourage new entrepreneurs, and sponsor networking and educational services to help develop skills necessary to bring new businesses and funding to the San Diego area. 

SDEE Businesses Directory


SDEE PLATINUM SPONSOR

ALT logo Alexandria

Struthers Family
Trust

Morrison Foerster

SDEE GOLD SPONSORS

BioMed Realty

Ted Jacobs
Executive Managing Director
Global Life Sciences Practices Group

SDEE SILVER SPONSORS

Takeda San Diego

SDEE BRONZE SPONSORS

Duane Morris MaxCyte Wagenknecht Law Group Bronze Sponsor Marsh & McLennan



  • Tuesday, September 24, 2019 at 04:00 PM

    Larger Than Life Science - Get On Board

    Please RSVP here: https://www.eventbrite.com/e/larger-than-life-science-get-on-board-tickets-70158087729
    Tuesday, October 01, 2019 at 05:00 PM

    Bootcamp

    Thursday, October 10, 2019 at 05:00 PM
    Green Acre Campus Pointe in San Diego, CA

    Founders Tales

    Come and hear local San Diego Biotech leaders speak about their experiences with starting companies, building teams, raising money, and developing their businesses. Sponsored by:        Featured Speakers Jeff Stafford CEO & Co-founder Jecure Therapeutics Jeff was most recently co-founder and CEO of Jecure Therapeutics, a company targeting the NLRP3 inflammasome and which was acquired by Genentech in 2018.  Prior to Jecure, Jeff was co-founder and CSO of Quanticel Pharmaceuticals, a drug discovery company based on a single cell genomics platform to target cancer stem cells.  Celgene acquired Quanticel in 2015.  Jeff has held senior management positions in both large pharma and small biotech, and his discovery teams are responsible for several compounds advanced into clinical trials, including the FDA-approved drugs, VotrientTM (pazopanib) and NesinaTM (alogliptin).  Jeff received his bachelor’s degree from UCLA and a Ph.D. for Cornell University.  He completed an NIH Postdoctoral Fellowship at Berkeley.   Kevin Lustig CEO & Co-founder, Scientist.com, Kalypsys, and Bio, Tech and Beyond Kevin is a scientist-entrepreneur with 35 years of research experience in academia, biotech and pharma. He co-founded the life science incubator Bio, Tech and Beyond in 2013, the award-winning R&D marketplace Scientist.com in 2007 and the biotech company Kalypsys in 2001. Prior to Kalypsys, he directed lead discovery at Tularik, a biotech company purchased by Amgen for $2 billion. He carried out postdoctoral work at Harvard Medical School after receiving a PhD degree from USCF. Kevin has a M.S. degree from the University of Missouri and an A.B. degree magna cum laude from Cornell University. His research discoveries have been published in Science, Nature, PNAS and other leading scientific journals and he has eight technology patents. He has twice been named one of the Life Science Industry’s 100 Most Inspiring People by PharmaVoice Magazine. In 2013, he was named "San Diego's Most Admired CEO" by the San Diego Business Journal. In 2018, Scientist.com was recognized as the 9th fastest growing US company by Inc. magazine and as the 12th best entrepreneurial company in America by Entrepreneur magazine.  Scientist.com was also recognized as one of America’s Best Places to Work by Inc. magazine in 2018 and 2019.   Claire Weston CEO & Founder, Reveal Biosciences Dr. Claire Weston is the Founder & CEO of Reveal Biosciences, a computational pathology company applying artificial intelligence to generate quantitative pathology data for preclinical research, clinical trials and patient diagnostics.  Reveal was founded in 2012 and grew organically, funded by revenue, until the company raised Series A in January 2019 from a syndicate lead by Intel Capital.  Reveal is collaborating with a team of leading US pathologists to expand their ImageDx pipeline of disease specific pathology decision support tools to increase accuracy, reproducibility and scale and lower the cost of healthcare.  Claire was awarded a PhD in from Cambridge University in the UK and has lead teams and projects focused on cancer biomarkers in both large pharma and start-up environments.  She has authored numerous peer-reviewed publications in leading journals including Science, and is a respected member of multiple professional organizations including the Digital Pathology Association.   Todd Harris CEO, Tyra Biosciences Todd Harris, Ph.D. is the Chief Executive Officer at Tyra Biosciences, a company focused on targeting new mechanisms of resistance in oncology. Previously, he was the founder of Sienna Labs, Inc. (now Sienna Biopharmaceuticals, Inc. SNNA) and served as a member of its board of directors since 2010, as its Chief Executive Officer from July 2010 until January 2016, and its Head of Corporate Development from January 2016 to November 2018. Previously, from 2008 to 2013, Dr. Harris was a consultant at McKinsey & Company in the Health Care Practice Division. Between 2006 and 2008, Dr. Harris held a graduate fellowship with the National Institute of Health. Dr. Harris received a B.S. in Engineering from Brigham Young University, an M.S. in Bioengineering from the University of California, San Diego, and a Ph.D. in Medical Engineering and Medical Physics from the Massachusetts Institute of Technology. Schedule 5:00 – 6:00 pm – Networking, Reception, and Exhibition6:00 – 6:10 pm – Introduction & 30 Second Pitch6:10 – 7:30 pm – Speaker Presentation and Discussion Cost Members: FreePlease RSVP belowExhibit tables are available to SDEE member companiesSDEE members can apply for the 30 Second Pitch Non-members: $25Please go here to purchase tickets.
    Thursday, October 17, 2019 at 05:30 PM · 5 rsvps
    New English Brewing Company in San Diego, CA

    October Happy Hour

    Come network with your fellow San Diego entrepreneurs at Happy Hour held at the New English Brewing Company in Sorrento Valley. Not a member yet? Just ask SDEE about the benefits of joining and/or ask members at the event about the benefits they've received from joining. Our members are happy to spread the word!  Everyone is welcome (registration is free!), SDEE members get 10% drinks discount.

  • Meet SDEE Community

    Thank You to SDEE Sponsors

    SDEE would like to thank its sponsors—ALT, Alexandria, Struthers Family Trust, Morrison Foerster, BioMed Realty, Ted Jacobs, BREX, Takeda, Union Bank, JP Morgan, Duane Morris, MaxCyte, Wagenknecht Law Group, Marsh & McLennan, and Longfellow—for supporting the organization in 2019. It’s through the contributions of funds, space, and leadership that we are able to bring you the events and engagements that drive growth and progression in our community. If you or your company would like to participate in sponsorship activities, please contact any member of the SDEE Executive Committee or simply email Danielle Hayes at dhayes@sdentrepreneurs.com. No contribution is too small, and all donations are dedicated to enhancing the growth of founders, startups, and their entrepreneurial endeavors.
    read more

    SDEE Launches New Entrepreneurial Boot Camp Series

    By Amy Duncan, Goldfish Consulting, Inc. Being an entrepreneur is challenging because there is so much to learn. It’s not just knowing about your product, but also understanding company formation, financing, and intellectual property. It’s no different for scientific founders with graduate degrees and years of experience. SDEE has regularly hosted workshops to aid entrepreneurs in getting started. Now they’re introducing the Entrepreneur Boot Camp. As a benefit to members, the Boot Camp is an 8-month program with monthly expert-led education sessions and small cohort mentoring sessions. Leading the way are Deborah Nguyen, PhD, Vice President, Biology, COI Pharmaceuticals, and Daniel Catron, Executive Director of Licensing and Business Development, Allele Biotechnology & Pharmaceuticals, Inc. With contributions from sponsors ALT, Morrison Foerster, JP Morgan, and Struthers Family Trust and help from experienced leaders in the community, they’re ready to kick off the inaugural SDEE Boot Camp with the first session scheduled in September 2019. I sat down with Nguyen and Catron to find out what SDEE Boot Camp is all about.
    read more
    See all news

  • News From SDEE Members

    Neuropore achieves $5 million (USD) milestone from UCB collaboration

    Neuropore announced advancement of UCB0599 to next phase.  UCB0599 is an orally bioavailable, brain barrier penetrant small molecule that prevents the oligomerization of alpha-synuclein. Alpha-synuclein oligomerization and aggregation is implicated in Parkinson’s disease and other degenerative diseases. By inhibiting misfolding and oligomerization of alpha-synuclein, it is believed that the progression of Parkinson’s disease can be slowed or halted. UCB0599 belongs to a series of molecules discovered by Neuropore, which were licensed to UCB in 2014 (Press Release)
    read more

    Neuropore introduces a 2nd drug into the clinic. Has an eye for Parkinson's disease and ALS.

    Neuropore Therapies announced that it has initiated a Phase 1 clinical trial in healthy volunteers with NPT520-34. This Phase 1 study is designed to evaluate the safety, tolerability and pharmacokinetics of NPT520-34. NPT520-34 is an orally bioavailable, blood-brain barrier penetrating small molecule. Its mode of action is attenuation of neuroinflammation and reduction of neurotoxic misfolded proteins in the central nervous system, key features of neurodegenerative diseases including Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS). Full press release: https://www.businesswire.com/news/home/20190508005227/en/Neuropore-Initiates-Phase-1-Clinical-Trial-Healthy  
    read more
    See all news or Share Your Own News

Attend SDEE Events Donate | Sponsor SDEE Become a Member

Connect with SDEE

Sign Up for SDEE Newsletter


SDEE PLATINUM SPONSORS

ALT San Diego Alexandria

Struthers Family
Trust

Morrison Foerster

SDEE GOLD SPONSORS

BioMed Realty

Ted Jacobs
Executive Managing Director
Global Life Sciences Practices Group

Brex logo

SDEE SILVER SPONSORS

Takeda San Diego Union Bank JP Morgan logo

SDEE BRONZE SPONSORS

Duane Morris MaxCyte Wagenknecht Barney and Barney Longfellow

SDEE is a nonprofit 501(c)(3) organization founded by local San Diego entrepreneurs
in order to provide a voice for the early stage start-up, to support new entrepreneurs and their companies,
and to sponsor networking and educational events
to help develop the skills necessary to bring funding, business, and jobs to the San Diego area.

© 2015 San Diego Entrepreneurs Exchange. All Rights Reserved